|
21 Jul 2019 |
Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis
|
|
18 Jul 2019 |
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-Mediated Diseases
|
|
18 Jul 2019 |
Inflection Biosciences and AUM Biosciences Announce Global License Agreement for PIM/PI3K/mTOR Inhibitors
|
|
18 Jul 2019 |
Boehringer Ingelheim Expands Idiopathic Pulmonary Fibrosis (IPF) Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics
|
|
17 Jul 2019 |
PureTech Acquires New Clinical-Stage Program LYT-100 to Treat Lymphedema
|
|
17 Jul 2019 |
Astellas and Frequency Therapeutics Enter into License Agreement for FX-322, a Regenerative Treatment Candidate for Hearing Loss
|
|
17 Jul 2019 |
Gotham Therapeutics and Mercachem Announce Progress in Compound Library Development Tailored for Epitranscriptomic Drug Discovery
|
|
16 Jul 2019 |
Skyhawk Therapeutics Announces Agreement with Genentech to Discover and Develop Small Molecule RNA Splicing Modifiers for Oncology and Neurodegenerative Diseases
|
|
16 Jul 2019 |
Convelo Therapeutics Enters Into Collaboration and Option to Acquire Agreement With Genentech to Discover Novel Remyelinating Therapies
|
|
16 Jul 2019 |
Sosei Heptares Enters Into Multi-target Research Collaboration and License Agreement With Genentech
|
|
16 Jul 2019 |
Imugene Enhances Portfolio with Compelling Oncolytic Virus from City of Hope, a Cancer Centre in Los Angeles, California
|
|
15 Jul 2019 |
AbbVie Enhances Early Stage Oncology Pipeline with Acquisition of Mavupharma
|
|
15 Jul 2019 |
Boehringer Ingelheim Acquires AMAL Therapeutics, Significantly Enriching Its Cancer Immunology Portfolio with Novel Cancer Vaccines Platform
|
|
15 Jul 2019 |
Recordati to acquire worldwide rights to Signifor® and Osilodrostat (LCI699)
|
|
15 Jul 2019 |
Gilead and Galapagos Enter Into Transformative Research and Development Collaboration
|
|
12 Jul 2019 |
Genmab and BliNK Biomedical Enter into Commercial License Agreement
|
|
11 Jul 2019 |
Report Package: Bispecific Antibodies
|
|
11 Jul 2019 |
vasopharm Closes € 9.5 million Financing Round
|
|
10 Jul 2019 |
AiCuris and Lysando join forces in the fight against antimicrobial resistance
|
|
10 Jul 2019 |
Jazz Pharmaceuticals Acquires Pre-clinical Pan-RAF Inhibitor Program from Redx Pharma
|
|
09 Jul 2019 |
Altimmune Signs Definitive Agreement to Acquire Spitfire Pharma, Inc. Adding NASH Drug Candidate to Portfolio
|
|
09 Jul 2019 |
Lyndra Therapeutics and Gilead Sciences to Collaborate on Development of Ultra-Long-Acting HIV Therapeutics
|
|
09 Jul 2019 |
Nimbus Therapeutics and Celgene Expand Alliance to Immunotherapy in Oncology
|
|
09 Jul 2019 |
IGM Biosciences Announces $102 Million Series C Financing to Advance its IgM Antibody Platform and Pipeline
|
|
09 Jul 2019 |
ADC Therapeutics Announces Final Close of Series E Financing Expansion
|
